Sotorasib + panitumumab beneficial for chemorefractory metastatic CRC
For patients with chemorefractory metastatic colorectal cancer, the KRAS G12C inhibitor sotorasib in combination with the epidermal growth factor receptor inhibitor panitumumab results in longer progression-free survival ...
Oct 24, 2023
0
0